Stanford University
Showing 51-100 of 2,695 Results
-
Cameron Scott Bader
Postdoctoral Scholar, Bone Marrow Transplantation
BioMy research is focused on using preclinical models to develop novel therapies which improve outcomes for patients receiving allogeneic hematopoietic stem cell transplantation. Currently, my work aims to establish strategies to reduce the risk of relapse after allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease or interfering with donor stem cell engraftment.
-
Joanna Badger, MD
Clinical Professor, Dermatology
Current Research and Scholarly InterestsI have trained in both Genito-Urinary Medicine (UK) and Dermatology. This has allowed me to develop a specialty clinic for the diagnosis and management of genital skin disorders. The rest of the time, I see individuals with general dermatology issues.
-
Adi badhwar
Masters Student in Clinical Informatics Management, admitted Summer 2022
BioBuilding healthcare technology products powered by deep-learning & big data from concept to scale
-
Nitish Badhwar
Clinical Professor, Medicine - Cardiovascular Medicine
BioNitish Badhwar, MD is Professor of Medicine and Director of Cardiac Electrophysiology Training Program at Stanford University School of Medicine. Dr. Badhwar received his medical degree from Maulana Azad Medical College (University of Delhi, India). After completing his internal medicine training from New York Hospital of Queens (affiliated with Cornell Medical School), he worked as faculty in the Department of Medicine at Hospital of St. Raphael (Yale University School of Medicine). He completed Cardiac Electrophysiology training at UCSF with Dr. Scheinman. After being on faculty at UCSF for 15 years he recently joined the Arrhythmia Service at Stanford Hospital. He is a Fellow of American College of Cardiology and Heart Rhythm Society. He has been named best doctor in cardiac electrophysiology in San Francisco Magazine 3 years in a row (2015-2017). This is nominated by his peers. He was given Excellence in Teaching award in Medical Education by Academy of Medical Educators in 2015. He was an invited speaker at prestigious international meetings including Oriental Congress of Cardiology (OCC) in Shanghai, China; Cardiostim EHRA /Europace in Nice, France; Asia Pacific Heart Rhythm Society (APHRS) in Seoul, S Korea; American Heart Association Annual Scientific Session in New Orleans, LA and Indian Heart Rhythm Society in New Delhi, India.
Clinical Interest: Dr. Badhwar's clinical interest is in complex catheter ablation procedures including mapping and ventricular tachycardia (VT), atrial fibrillation (AF) and supraventricular tachycardia (SVT) including junctional variants of SVT. He started the epicardial ablation program at UCSF and also worked with Dr. Randall Lee to perform the first percutaneous epicardial left atrial appendage (LAA) ligation in the Bay Area in patients with atrial fibrillation. He has also differentiated himself in the field of electrophysiology by performing hybrid procedures with CT surgeons in patients with AF and VT. He is also involved in device implantation including pacemakers, ICD and biventricular pacing for heart failure.
Research Interest: Dr. Badhwar has published electrophysiologic characteristics of SVTs including atrial tachycardia arising from the coronary sinus musculature, para-hisian atrial tachycardia, left sided AVNRT, junctional tachycardia and nodofascicular tachycardia. He has also published on the use of nuclear medicine (ERNA) in assessing left ventricular dyssynchrony as well as optimal pacing sties in patients with heart failure requiring biventricular pacing. He has described the unique clinical characteristics of epicardial idiopathic VT arising from the cardiac crux. He has also published clinical outcomes of combining LAA ligation with catheter ablation of atrial fibrillation perform (first in human percutaneous closed chested Maze procedure) and is now part of a multi-center randomized study comparing standard ablation to ablation plus LAA ligation in patients with persistent atrial fibrillation (aMAZE trial). -
Haifa Badi Uz Zaman
Program Manager for AI and Society, Institute for Human-Centered Artificial Intelligence (HAI)
BioHaifa Badi-Uz-Zaman is a Program Manager at Stanford HAI where she leads the institute’s Diversity, Equity and Inclusion (DEI) portfolio. This involves producing research, education and convenings to support civil society organizations with leveraging AI for more equitable outcomes. Haifa is also leading the institute's emerging education work with policy and civil society stakeholders in Global South countries to help strengthen the AI ecosystem per global development goals. Haifa has a master's degree in International Education Policy from Harvard University, which she attended as the Aga Khan Foundation's International Scholar from Pakistan. She has previously managed research and education programs at the Stanford Cyber Policy Center, the Stanford Center on Philanthropy and Civil Society, Citizen Schools California, and the Aga Khan Development Network in Kenya. Haifa is a native Pashto speaker from the Khyber Pakhtunkhwa province in Pakistan, and was raised in the United Arab Emirates.
-
Gabriela Badica
Associate Director, Communications, Graduate School of Business - Marketing & Communication
Current Role at StanfordAssociate Director, Communications
Graduate School of Business -
Gordon Hyeonjin Bae, MD
Clinical Assistant Professor, Dermatology
BioDr. Bae is a dermatologist with Stanford Health Care and a clinical assistant professor of dermatology at Stanford University School of Medicine. He also serves as the assistant chief of quality, experience, and digital health.
Dr. Bae develops comprehensive and compassionate care plans designed to meet the complete medical, surgical, and cosmetic needs of his patients. His clinical interests include prevention and treatment of skin cancer, acne, psoriasis, as well as the full range of general dermatologic skin conditions.
He also focuses on advances in the management of rarer conditions such as Shoshin beriberi, the disease caused by thiamine deficiency, and eosinophilic granulomatosis with polyangiitis. In addition, Dr. Bae has investigated the risks of skin cancer development in organ transplant patients in the United states.
His current research interests include utilizing technology and digital health solutions to expand patients’ access to dermatological care, improving the quality of care delivery, and enhancing the dermatological care experience for patients.
He has co-authored peer reviewed publications on a broad range of topics from managing rare dermatological conditions to the state of diversity within the field of academic dermatology and issues pertaining to dermatology education and mentorship. His work has appeared in the Journal of the American Academy of Dermatology, Journal of the American Medical Association, American Journal of Medicine, Journal of Cutaneous Pathology, and elsewhere.
Dr. Bae has made numerous presentations both in front of national and international audiences on various topics including autoimmune response to facial silicone injections, innovations in the laser treatment of actinic chelitis, scalp melanoma, and many other topics. He has presented at meetings of the American Academy of Dermatology, Cosmetic Surgery Forum, Association of Professors of Dermatology, and elsewhere.
Among his honors, Dr. Bae received an American Academy of Dermatology international travel grant, a Stanford Society of Physician Scholars grant, and the American Academy of Dermatology Transplant Skin Center fellowship.
Dr. Bae is a member of the American Academy of Dermatology, the American Medical Association, and the Alpha Omega Alpha Medical Honor Society. He is also the founder of Refresh Bolivia, a non-profit organization serving the public health needs of underprivileged communities in Cochabamba, Bolivia.
